Advertisement
Table 1 Clinical characteristics of the studied groups (medians and IQR)
| fhMetS (n = 78) | Control group (n = 12) | p | |
|---|---|---|---|
| Age (years) | 35.0 (31.0–39.0 ) | 32.5 (27.0–37.0 ) | 0.256 |
| Body mass (kg) | 75.5 (59.0–93.0) | 69.5 (58.0–81.0) | 0.267 |
| WC (cm) | 84.5 (70.0–97.5) | 77.9 ( 67.0–88.1) | 0.102 |
| BMI (kg/m2) | 25.3 (21.9–28.7 ) | 23.6 (22.5–26.0) | 0.499 |
| WHR | 0.9 (0.8–0.9) | 0.8 (0.8–0.9) | 0.365 |
| Creatinine (mmol/L) | 79.56 (53.04–106.08) | 53.04 (61.88–97.24) | 0.681 |
| eGFR (ml/min) | 84.4 (74.9–92.7) | 82.3 (71.7–89.9) | 0.420 |
| Uric acid (umol/L) | 261.71 (220.0–339.0) | 261.72 (237.92–285.5) | 0.879 |
| AST (U/L) | 19.0 (16.0–24.0) | 17.1(13.0–22.0) | 0.248 |
| ALT (U/L) | 22.0 (15.0–32.0) | 13.5 (10.0–22.5) | 0.118 |
| ESR (mm) | 7.0 (4.0–13.5) | 8.0 (6.0–16.0) | 0.462 |
| WBC (G/L) | 6.1 (5.1–7.2) | 6.9 (5.2–9.7) | 0.310 |
| hsCRP (mg/L) | 1.3 (0.8–2.5) | 1.1 (0.4–5.8) | 0.704 |
